JP2023550543A5 - - Google Patents
Info
- Publication number
- JP2023550543A5 JP2023550543A5 JP2023551946A JP2023551946A JP2023550543A5 JP 2023550543 A5 JP2023550543 A5 JP 2023550543A5 JP 2023551946 A JP2023551946 A JP 2023551946A JP 2023551946 A JP2023551946 A JP 2023551946A JP 2023550543 A5 JP2023550543 A5 JP 2023550543A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- alkyl
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063108660P | 2020-11-02 | 2020-11-02 | |
| US63/108,660 | 2020-11-02 | ||
| PCT/US2021/057563 WO2022094400A1 (en) | 2020-11-02 | 2021-11-01 | Bicyclic compounds and uses thereof for the treatment of diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550543A JP2023550543A (ja) | 2023-12-01 |
| JP2023550543A5 true JP2023550543A5 (https=) | 2024-11-06 |
Family
ID=81384389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023551946A Pending JP2023550543A (ja) | 2020-11-02 | 2021-11-01 | 二環式化合物及び疾患の治療のためのその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240025903A1 (https=) |
| EP (1) | EP4236944A4 (https=) |
| JP (1) | JP2023550543A (https=) |
| KR (1) | KR20230104191A (https=) |
| CN (2) | CN119684295A (https=) |
| AR (1) | AR124637A1 (https=) |
| AU (1) | AU2021371026A1 (https=) |
| CA (1) | CA3196582A1 (https=) |
| CL (2) | CL2023001195A1 (https=) |
| IL (1) | IL302465A (https=) |
| MX (1) | MX2023004942A (https=) |
| WO (1) | WO2022094400A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240121239A (ko) * | 2021-12-17 | 2024-08-08 | 아티라 파마, 인코포레이티드 | 질환 치료를 위한 이환식 화합물의 용도 |
| EP4518864A1 (en) * | 2022-05-04 | 2025-03-12 | Athira Pharma, Inc. | Methods of treating neuropathies |
| JP2025515045A (ja) * | 2022-05-04 | 2025-05-13 | アティラ・ファーマ・インコーポレイテッド | 神経炎症病態を治療する方法 |
| EP4618996A1 (en) | 2022-11-18 | 2025-09-24 | Athira Pharma, Inc. | Methods of treating inflammatory conditions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184223B1 (en) * | 1995-10-27 | 2001-02-06 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
| AU2003284120A1 (en) * | 2002-10-17 | 2004-05-04 | Myriad Genetics, Inc. | Reverse-turn mimetics and composition and methods relating thereto |
| US7192976B2 (en) * | 2002-12-21 | 2007-03-20 | Angion Biomedica Corporation | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| AU2005289560A1 (en) * | 2004-09-28 | 2006-04-06 | Angion Biomedica Corp. | Small molecule modulators of cytokine activity |
| US7879898B1 (en) * | 2006-02-14 | 2011-02-01 | Angion Biomedica Corp. | Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease |
| EP1947085A1 (en) * | 2007-01-19 | 2008-07-23 | Laboratorios del Dr. Esteve S.A. | Substituted indole sulfonamide compounds, their preparation and use as medicaments |
| CN102186853A (zh) * | 2008-10-14 | 2011-09-14 | 株式会社棱镜生物实验室 | 治疗癌症α-螺旋模拟物 |
| WO2014025832A1 (en) * | 2012-08-06 | 2014-02-13 | University Of Southern California | Wnt modulators for the protection, mitigation and treatment of radiation injury |
| WO2017047762A1 (ja) * | 2015-09-18 | 2017-03-23 | 国立大学法人鳥取大学 | 低分子化合物による癌と線維化の抑制と再生促進の効果 |
-
2021
- 2021-11-01 CN CN202411623883.1A patent/CN119684295A/zh active Pending
- 2021-11-01 MX MX2023004942A patent/MX2023004942A/es unknown
- 2021-11-01 EP EP21887720.7A patent/EP4236944A4/en active Pending
- 2021-11-01 AR ARP210103033A patent/AR124637A1/es unknown
- 2021-11-01 WO PCT/US2021/057563 patent/WO2022094400A1/en not_active Ceased
- 2021-11-01 US US18/032,918 patent/US20240025903A1/en active Pending
- 2021-11-01 IL IL302465A patent/IL302465A/en unknown
- 2021-11-01 CN CN202180079749.8A patent/CN116568301A/zh active Pending
- 2021-11-01 KR KR1020237018061A patent/KR20230104191A/ko active Pending
- 2021-11-01 CA CA3196582A patent/CA3196582A1/en active Pending
- 2021-11-01 JP JP2023551946A patent/JP2023550543A/ja active Pending
- 2021-11-01 AU AU2021371026A patent/AU2021371026A1/en active Pending
-
2023
- 2023-04-26 CL CL2023001195A patent/CL2023001195A1/es unknown
-
2024
- 2024-02-02 CL CL2024000340A patent/CL2024000340A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023550543A5 (https=) | ||
| CA2505195A1 (en) | Quinazolinones as potassium channel modulators | |
| JP2020502092A5 (https=) | ||
| RU2019131111A (ru) | ПРОИЗВОДНОЕ ГЕТЕРОАРИЛ[4,3-с]ПИРИМИДИН-5-АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКИЕ ПРИМЕНЕНИЯ | |
| RU2009132189A (ru) | Новые 2-аминооксазолины в качестве лигандов taar1 | |
| CA2441565A1 (en) | Bisarylamines as potassium channel openers | |
| JP2014051526A5 (https=) | ||
| JP2012515166A5 (https=) | ||
| JP2016534134A5 (https=) | ||
| JP2018502912A5 (https=) | ||
| JP2018505898A5 (https=) | ||
| TN2015000382A1 (en) | Perfluorinated cyclopropyl fused 1,3- oxazin -2- amine compounds as beta- secretase inhibitors and methods of use | |
| DE602004017316D1 (de) | Heteroaryl-tetrahydropyridylverbindungen, die sich für die behandlung bzw. die prävention von schmerzen eignen | |
| JP2013505903A5 (https=) | ||
| RU2002128352A (ru) | Производные 4,5-дигидро-1н-пиразола, обладающие cb1-антагонистической активностью | |
| JP2013525458A5 (https=) | ||
| JP2024517498A5 (https=) | ||
| JP2011527686A5 (https=) | ||
| JPWO2002010101A1 (ja) | アミド化合物を配位子とする遷移金属錯体を用いたアルコールの製造方法 | |
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| NZ590951A (en) | Cyclic nucleotide phosphodiesterases PDE10 inhibitors for treating neurological disorders | |
| JP2013533253A5 (https=) | ||
| MX2016008842A (es) | Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos. | |
| JP2023509944A5 (https=) | ||
| RU2007116987A (ru) | Новые соединения |